In the literature, while there are studies that provide insight into ESR2/ERβ expression profiles across different tissues and cancer types, there remains a notable gap in compact and comprehensive analyses of ESR2 mRNA expression levels across diverse tumor types coupled with an exploration of its potential functional implications. The gene discussed is ESR2; the disease is cancer.